Core Insights - Odysight.ai Inc. has successfully transitioned from its legacy medical business to focus on high-value sectors such as aerospace, defense, and industrial markets, leveraging its AI-powered visual sensing technology [3][4]. Financial Performance - Total revenues for the year ended December 31, 2025, were $3.0 million, a decrease from approximately $4.0 million in 2024 [10]. - Core revenues from the vision-based PdM and CBM platform grew approximately 23% year-over-year, indicating increasing commercial adoption [5][11]. - The company reported a net loss of $17 million for 2025, compared to a net loss of $11.8 million in 2024 [15][26]. Operational Highlights - The backlog as of December 31, 2025, was approximately $13.8 million, providing revenue visibility into 2026 and beyond [5][12]. - The company ended the year with a cash balance of approximately $26 million and no debt, positioning it well for future growth [8][15]. - Significant milestones included the delivery of systems for UAVs under a contract with a top global defense contractor and successful technology demonstrations with various military and industrial partners [5][6]. Strategic Initiatives - The company expanded its international presence with new teams in the U.S. and EU, and appointed a Chief Business Officer to enhance its market reach [5][6]. - Odysight.ai uplisted to the Nasdaq Capital Market in February 2025, raising approximately $23.7 million through a public offering [5][15]. - The Board of Directors is exploring a potential dual listing on the Tel Aviv Stock Exchange to broaden access to investors [5][8].
Odysight.ai Reports Full Year 2025 Financial Results and Strategic Progress Across Aerospace, Defense, and Industrial Markets